Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA140472
Max Phase: Preclinical
Molecular Formula: C9H5F2NO
Molecular Weight: 181.14
Molecule Type: Small molecule
Associated Items:
ID: ALA140472
Max Phase: Preclinical
Molecular Formula: C9H5F2NO
Molecular Weight: 181.14
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Oc1c(F)cc(F)c2cccnc12
Standard InChI: InChI=1S/C9H5F2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H
Standard InChI Key: AEPLVAHGESFRJT-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 181.14 | Molecular Weight (Monoisotopic): 181.0339 | AlogP: 2.22 | #Rotatable Bonds: 0 |
Polar Surface Area: 33.12 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.48 | CX Basic pKa: 3.97 | CX LogP: 2.11 | CX LogD: 1.84 |
Aromatic Rings: 2 | Heavy Atoms: 13 | QED Weighted: 0.68 | Np Likeness Score: -0.91 |
1. Lukovits I, Lopata A.. (1980) Decomposition of pharmacological activity indices into mutually independent components using principal component analysis., 23 (4): [PMID:7381845] [10.1021/jm00178a018] |
Source(1):